ALS 미래 성장

Future 기준 확인 5/6

ALS (는) 각각 연간 28.6% 및 7.2% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 28.5% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 27.5% 로 예상됩니다.

주요 정보

28.6%

수익 성장률

28.5%

EPS 성장률

Professional Services 수익 성장	11.7%
매출 성장률	7.2%
향후 자기자본 수익률	27.5%
애널리스트 커버리지	Good
마지막 업데이트	21 Nov 2024

최근 미래 성장 업데이트

업데이트 없음

Recent updates

수익 및 매출 성장 예측

DB:CP4 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (AUD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
3/31/2027	3,409	386	361	582	9
3/31/2026	3,168	341	292	518	10
3/31/2025	2,983	282	229	399	9
9/30/2024	2,703	6	234	375	N/A
6/30/2024	2,582	10	216	362	N/A
3/31/2024	2,462	13	198	350	N/A
12/31/2023	2,420	138	220	382	N/A
9/30/2023	2,379	264	241	415	N/A
6/30/2023	2,329	270	268	427	N/A
3/31/2023	2,279	275	294	440	N/A
9/30/2022	2,051	260	222	342	N/A
6/30/2022	2,002	225	195	314	N/A
3/31/2022	1,952	190	168	287	N/A
12/31/2021	2,023	183	187	297	N/A
9/30/2021	1,946	176	207	307	N/A
6/30/2021	1,854	173	198	286	N/A
3/31/2021	1,761	170	189	266	N/A
12/31/2020	1,768	113	170	260	N/A
9/30/2020	1,774	57	151	254	N/A
6/30/2020	1,814	67	145	257	N/A
3/31/2020	1,854	76	138	259	N/A
12/31/2019	1,806	122	N/A	N/A	N/A
9/30/2019	1,758	167	107	222	N/A
6/30/2019	1,711	167	108	220	N/A
3/31/2019	1,665	167	110	219	N/A
12/31/2018	1,611	159	N/A	N/A	N/A
9/30/2018	1,556	150	136	216	N/A
6/30/2018	1,502	108	N/A	201	N/A
3/31/2018	1,447	66	N/A	186	N/A
12/31/2017	1,398	57	N/A	N/A	N/A
9/30/2017	1,348	48	N/A	154	N/A
6/30/2017	1,305	75	N/A	165	N/A
3/31/2017	1,262	102	N/A	175	N/A
9/30/2016	1,157	-230	N/A	179	N/A
6/30/2016	1,198	-230	N/A	174	N/A
3/31/2016	1,239	-230	N/A	170	N/A
12/31/2015	1,394	-208	N/A	184	N/A
9/30/2015	1,424	-176	N/A	197	N/A
6/30/2015	1,423	-175	N/A	206	N/A
3/31/2015	1,422	-173	N/A	215	N/A
12/31/2014	1,416	-29	N/A	218	N/A
9/30/2014	1,410	115	N/A	221	N/A
6/30/2014	1,397	134	N/A	227	N/A
3/31/2014	1,384	153	N/A	234	N/A

애널리스트 미래 성장 예측

수입 대 저축률: CP4 의 연간 예상 수익 증가율( 28.6% )이 saving rate( 1% 보다 높습니다. ).

수익 vs 시장: CP4 의 연간 수익( 28.6% ) German 시장( 21.1% 보다 빠르게 성장할 것으로 예상됩니다. 21.1% 연간).

고성장 수익: CP4 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: CP4 의 수익(연간 7.2% ) German 시장( 5.6% 보다 빠르게 성장할 것으로 예상됩니다. 5.6% 연간).

고성장 수익: CP4 의 수익(연간 7.2% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: CP4 의 자본 수익률은 3년 내에 최고 수준이 될 것으로 예상됩니다. ( 27.5 %)

ALS 미래 성장

Future 기준 확인 5/6

주요 정보

최근 미래 성장 업데이트

Recent updates

Now 21% overvalued

Now 20% overvalued

ALS Limited Appoints Dayna Field as General Counsel and Company Secretary, Effective 1 October 2024

ALS Limited Announces Resignation of Michael Pearson as Company Secretary & General Counsel

ALS Limited to Report Fiscal Year 2025 Results on May 27, 2025

Final dividend of AU$0.039 announced

New minor risk - Earnings quality

Full year 2024 earnings released: EPS: AU$0.027 (vs AU$0.57 in FY 2023)

ALS Limited (ASX:ALQ) agreed to acquire Wessling Holding Gmbh & Co.Kg.

Now 20% undervalued after recent price drop

Now 20% undervalued

ALS Limited, Annual General Meeting, Jul 31, 2024

ALS Limited Appoints Stuart Hutton as Chief Financial Officer, Effective 1 February 2024

Investor sentiment improves as stock rises 19%

ALS Limited Announces Stepdown of Luis Damasceno as Chief Financial Officer, Effective 19 January 2024

ALS Limited Appoints Heike Truöl as Chief Strategy Officer

ALS Limited to Report Fiscal Year 2024 Results on May 21, 2024

Independent Chairman recently bought €364k worth of stock

ALS Limited Announces Board Changes

Upcoming dividend of AU$0.19 per share at 3.4% yield

ALS Limited Declares Final Dividend for the Fiscal Year 2023, Payable on 6 July 2023

Full year 2023 earnings released: EPS: AU$0.57 (vs AU$0.39 in FY 2022)

ALS Limited Appoints Malcolm Deane as Managing Director

Insufficient new directors

Upcoming dividend of AU$0.20 per share

First half 2023 earnings released: EPS: AU$0.30 (vs AU$0.15 in 1H 2022)

ALS Limited Declares an Unfranked Interim Dividend for the First Half of Fiscal Year 2023, Payable on 16 December 2022

ALS Limited Appoints Peter Possemiers as an Independent Non-Executive Director Effective 1 November 2022

ALS Limited Declares Final Dividend

ALS Limited (ASX:ALQ) announces an Equity Buyback for 9,000,000 shares, representing 1.86% for AUD 100 million.

ALS Limited to Report Fiscal Year 2023 Results on May 24, 2023

ALS Limited (ASX:ALQ) made an non-binding indicative offer to acquire HRL Holdings Limited (ASX:HRL) for AUD 79 million.

ALS Limited (ASX:ALQ) made an non-binding indicative offer to acquire HRL Holdings Limited (ASX:HRL) for AUD 79 million.

Independent Non-Executive Director recently bought €59k worth of stock

Independent Non-Executive Director recently bought €59k worth of stock

Upcoming dividend of AU$0.17 per share

Full year 2022 earnings released: EPS: AU$0.40 (vs AU$0.36 in FY 2021)

ALS Limited Declares Dividend for the Period Ended March 31, 2022, Payable on July 4, 2022

ALS Limited Declares Dividend for the Period Ended March 31, 2022, Payable on July 4, 2022

ALS Limited to Report First Half, 2023 Results on Nov 14, 2022

Insufficient new directors

Investor sentiment improved over the past week

Insufficient new directors

ALS Limited (ASX:ALQ) agreed to acquire MinAnalytical Laboratory Services Pty Ltd. from Perenti Global Limited (ASX:PRN) for AUD 39 million.

Upcoming dividend of AU$0.16 per share

First half 2022 earnings released: EPS AU$0.15 (vs AU$0.14 in 1H 2021)

Independent Non-Executive Director recently bought €73k worth of stock

Investor sentiment improved over the past week

Upcoming dividend of AU$0.15 per share

Full year 2021 earnings released: EPS AU$0.36 (vs AU$0.16 in FY 2020)

ALS Limited Declares Final Dividend, payable on July 5, 2021

ALS Limited (ASX:ALQ) entered in an agreement to acquire Investiga.

New 90-day high: €6.90

New 90-day high: €6.45

ALS Limited to Report Fiscal Year 2021 Final Results on Jun 23, 2021

First half 2021 earnings released: EPS AU$0.15

ALS Limited, Annual General Meeting, Jul 28, 2021

Revenue misses expectations

ALS Limited to Report Fiscal Year 2021 Results on May 26, 2021

New 90-day high: €6.00

New 90-day high: €5.80

New 90-day high: €5.75

New 90-day high - €5.50

New 90-day high - €5.40

New 90-day high - €4.58

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견